377 related articles for article (PubMed ID: 26143297)
41. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.
Peterli R; Wölnerhanssen B; Peters T; Devaux N; Kern B; Christoffel-Courtin C; Drewe J; von Flüe M; Beglinger C
Ann Surg; 2009 Aug; 250(2):234-41. PubMed ID: 19638921
[TBL] [Abstract][Full Text] [Related]
42. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.
Laferrère B; Heshka S; Wang K; Khan Y; McGinty J; Teixeira J; Hart AB; Olivan B
Diabetes Care; 2007 Jul; 30(7):1709-16. PubMed ID: 17416796
[TBL] [Abstract][Full Text] [Related]
43. Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia.
Lee CJ; Brown T; Magnuson TH; Egan JM; Carlson O; Elahi D
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1208-12. PubMed ID: 23666968
[TBL] [Abstract][Full Text] [Related]
44. Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.
Nielsen S; Svane MS; Kuhre RE; Clausen TR; Kristiansen VB; Rehfeld JF; Holst JJ; Madsbad S; Bojsen-Moller KN
Physiol Rep; 2017 Feb; 5(3):. PubMed ID: 28202805
[TBL] [Abstract][Full Text] [Related]
45. Mucosal and hormonal adaptations after Roux-en-Y gastric bypass.
Feris F; McRae A; Kellogg TA; McKenzie T; Ghanem O; Acosta A
Surg Obes Relat Dis; 2023 Jan; 19(1):37-49. PubMed ID: 36243547
[TBL] [Abstract][Full Text] [Related]
46. A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.
Jirapinyo P; Jin DX; Qazi T; Mishra N; Thompson CC
Obes Surg; 2018 Mar; 28(3):615-626. PubMed ID: 28871519
[TBL] [Abstract][Full Text] [Related]
47. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
48. Jejunal administration of glucose enhances acyl ghrelin suppression in obese humans.
Tamboli RA; Sidani RM; Garcia AE; Antoun J; Isbell JM; Albaugh VL; Abumrad NN
Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E252-9. PubMed ID: 27279247
[TBL] [Abstract][Full Text] [Related]
49. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
[TBL] [Abstract][Full Text] [Related]
50. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
51. Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.
Promintzer-Schifferl M; Prager G; Anderwald C; Mandl M; Esterbauer H; Shakeri-Leidenmühler S; Pacini G; Stadler M; Bischof MG; Ludvik B; Luger A; Krebs M
Obesity (Silver Spring); 2011 Jul; 19(7):1420-6. PubMed ID: 21494227
[TBL] [Abstract][Full Text] [Related]
52. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
[TBL] [Abstract][Full Text] [Related]
53. Differential GIP/GLP-1 intestinal cell distribution in diabetics' yields distinctive rearrangements depending on Roux-en-Y biliopancreatic limb length.
Palha AM; Pereira SS; Costa MM; Morais T; Maia AF; Guimarães M; Nora M; Monteiro MP
J Cell Biochem; 2018 Sep; 119(9):7506-7514. PubMed ID: 29761876
[TBL] [Abstract][Full Text] [Related]
54. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
[TBL] [Abstract][Full Text] [Related]
55. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.
Mumphrey MB; Patterson LM; Zheng H; Berthoud HR
Neurogastroenterol Motil; 2013 Jan; 25(1):e70-9. PubMed ID: 23095091
[TBL] [Abstract][Full Text] [Related]
56. Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
Jørgensen NB; Dirksen C; Bojsen-Møller KN; Jacobsen SH; Worm D; Hansen DL; Kristiansen VB; Naver L; Madsbad S; Holst JJ
Diabetes; 2013 Sep; 62(9):3044-52. PubMed ID: 23649520
[TBL] [Abstract][Full Text] [Related]
57. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
Carr RD; Larsen MO; Jelic K; Lindgren O; Vikman J; Holst JJ; Deacon CF; Ahrén B
J Clin Endocrinol Metab; 2010 Feb; 95(2):872-8. PubMed ID: 20008019
[TBL] [Abstract][Full Text] [Related]
58. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
[TBL] [Abstract][Full Text] [Related]
59. The impact of the repair of staple line dehiscence in post-RYGB patients on glucose homeostasis and gut hormones--a preliminary study.
Durczynski A; Szymanski D; Nowicki M; Hogendorf P; Wojciechowska-Durczyńska K; Czupryniak L; Strzelczyk J
Endokrynol Pol; 2013; 64(1):7-12. PubMed ID: 23450441
[TBL] [Abstract][Full Text] [Related]
60. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction.
Rabiee A; Magruder JT; Salas-Carrillo R; Carlson O; Egan JM; Askin FB; Elahi D; Andersen DK
J Surg Res; 2011 May; 167(2):199-205. PubMed ID: 21414635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
